The patented technology for the treatment of erectile dysfunction caused by neoplasms and degeneration of the tissues of the prostate gland, as well as with its imbalance, the clinical trials of which ended in May 2025, gave a staggering result. At the first stage, artificial intelligence analyzes the analyzes and physico biological parameters of the patient, after which it makes the calculation of the dosage of the supporting drug (in our clinic this is sildenafil - Viagra). After that, our new laserjesterblast technology is connected - this is a complex therapy based on the Rubin high -frequency laser of a low wave length, artificial intelligence calculates the number of impulses, the wavelength of the waves in the tissues of the prostate. The irradiation itself takes 2.5 hours, a chilling therapy of 2 weeks, after which the patient leaves our clinic. Therapy restores erectile function in 93% of cases. Relapses make up less than 1%.
